RenovoRx, Inc.
RNXT
$2.00
-$0.21-9.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 198.49% | 520.42% | 2,511.63% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 198.49% | 520.42% | 2,511.63% | -- | -- |
| Cost of Revenue | 25.20% | 237.23% | -- | -- | -- |
| Gross Profit | 300.96% | 702.74% | 1,751.16% | -- | -- |
| SG&A Expenses | 78.66% | 53.58% | 41.38% | 21.04% | 5.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.24% | 16.16% | 18.34% | 23.06% | 15.97% |
| Operating Income | -15.04% | -5.73% | -8.57% | -13.89% | -9.52% |
| Income Before Tax | -15.20% | -20.78% | -26.71% | -21.19% | -31.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.20% | -20.78% | -26.71% | -21.19% | -31.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.20% | -20.78% | -26.71% | -21.19% | -31.44% |
| EBIT | -15.04% | -5.73% | -8.57% | -13.89% | -9.52% |
| EBITDA | -123.52% | -294.52% | -- | -400.46% | -21.63% |
| EPS Basic | 15.17% | 15.05% | 17.95% | 38.76% | 38.94% |
| Normalized Basic EPS | 19.59% | 19.20% | 22.15% | 39.22% | 38.95% |
| EPS Diluted | 15.17% | 15.05% | 17.95% | 38.76% | 38.94% |
| Normalized Diluted EPS | 19.59% | 19.20% | 22.15% | 39.22% | 38.95% |
| Average Basic Shares Outstanding | 34.41% | 40.21% | 58.66% | 73.81% | 95.44% |
| Average Diluted Shares Outstanding | 34.41% | 40.21% | 58.66% | 73.81% | 95.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |